Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71205-812

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71205-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figr1 (Figr1)

Figr1 (Figr1)
A pharmacokinetic PK fold change chart showing the effects of various interacting drugs on venlafaxine and its metabolite (ODV) Cmax and AUC values. The chart includes drugs like Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium with recommended clinical notes such as dose adjustment advice and cautions. The x-axis represents the change relative to a reference value, ranging from 0 to 3.*
FDA Label Image

Figr2 (Figr2)

Figr2 (Figr2)
A dot plot chart showing the pharmacokinetic fold change and 90% confidence interval for various interacting drugs with their analytes. The chart includes drugs such as Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium with recommendations ranging from no dose adjustment to avoiding concomitant use.*
FDA Label Image

Figr3 (Figr3)

Figr3 (Figr3)
A scatter plot chart showing fold changes and 90% confidence intervals for venlafaxine pharmacokinetics in various special populations. The x-axis represents change relative to the reference value, from 0 to 3.5. The chart compares Cmax and AUC values for venlafaxine and its ODV metabolite in populations including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender, with recommendations on dose adjustment noted.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

71205-812-30 (Venlafaxine Hydrochloride 30 Capsules)

71205-812-30 (Venlafaxine Hydrochloride 30 Capsules)
Label for Venlafaxine Hydrochloride 37.5 mg extended release capsules by Proficient Rx LP. The label includes dosage form details, imprint description of the capsules (white to off white, round to oval gelatin capsule with 'V' and '9' in black), package size (#30), manufacturer Annora Pharma Pvt. Ltd., and storage instructions. Contains NDC 71205-812 and barcodes.*
FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Venlafaxinestructure (Venlafaxinestructure)
Chemical structure of Venlafaxine Hydrochloride, depicting its molecular arrangement including a chiral center, a methoxyphenyl group, a cyclohexanol moiety, and a dimethylaminoethyl side chain with a hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.